Collaboration for pharmaceutical engineering and science
You are here: members › Gary Blau › Contributions
Gabapentin Population Model for PK Parameter Individualization
0.0 out of 5 stars
12 Sep 2011 | Tools | Contributor(s): Jose Miguel Lainez, Linas Mockus, Gary Blau, Seza Orcun, Rex Reklaitis
Generates individual PK parameters based on few samples and the population prior
Dose regimen individualization
24 Aug 2011 | Tools | Contributor(s): Jose Miguel Lainez, Linas Mockus, Gary Blau, Seza Orcun, Rex Reklaitis
Pharmacokinetic based design of individualized dosage regimens
10 May 2011 | Teaching Materials | Contributor(s): Jose Miguel Lainez, Gary Blau, Linas Mockus, Seza Orcun, Rex Reklaitis
Clinical trials and health care studies generate an enormous amount of data. This data is used by pharmaceutical companies during new drug development processes to characterize patient populations and determine a standardized dosage regimen for new patients. Nevertheless, the knowledge embedded...